Oral presentation of CARTITUDE-1 study data showcases long-term outcomes after a single infusion of CARVYKTI ® with one-third of patients with relapsed/refractory multiple myeloma progression-free for ...

Learn 12 critical neurological warning signs that demand emergency care. Recognize dangerous combinations of dizziness, ...

Road safety and breakdown organisation GEM Motoring Assist has produced a line-up of handy information to assist older p ...

This condition is caused by nerve ... peripheral nervous system. Symptoms include varying degrees of numbness, tingling, and weakness in the legs and feet, and can involve the trunk and arms. GBS ...

Romberg test was not performed before the intervention due to trunk instability; after treatment participants presented minimal balance changes ... peripheral nerves are relatively scarce, given that ...

Virus’ strategy to maintain persistent infection discovered in Ohio State studyA study by virologists from the Department of ...

In GBS, tanruprubart is designed to seek out C1q and prevent its binding to targets on peripheral nerves. Tanruprubart is administered intravenously and has been observed to act almost immediately ...

at the 2025 Peripheral Nerve Society (PNS) Annual Meeting being held May 17-20, 2025 in Edinburgh, UK. GBS is a neuromuscular emergency and rare autoimmune disease that affects at least 150,000 ...

Annexon's lead investigational therapy, tanruprubart, is a first-of-its kind selective, targeted and rapid-acting agent designed to reduce inflammation and nerve damage by stopping C1q activity in the ...

at the 2025 Peripheral Nerve Society (PNS) Annual Meeting being held May 17-20, 2025 in Edinburgh, UK. GBS is a neuromuscular emergency and rare autoimmune disease that affects at least 150,000 people ...